Investigator Meetings in Clinical Trials: Strengthening Site Preparedness and Study Compliance
Investigator Meetings serve as key touchpoints between sponsors, CROs, and clinical trial sites before study initiation or when major changes occur. They ensure that all participating sites receive consistent, thorough training on the study protocol, Good Clinical Practice (GCP), investigational product management, and operational logistics. Investigator meetings foster a sense of collaboration, encourage protocol adherence, and minimize errors that could impact data integrity or participant safety.
Click to read the full article.